Yahoo Web Search

    • Why NVAX Stock Has a Competitive Edge

      Why NVAX Stock Has a Competitive Edge

      InvestorPlace· 4 days ago

      Despite delays in obtaining approval for its Covid-19 vaccine, Novavax (NASDAQ:NVAX) has a competitive edge compared to its peers. It ...

    • Iowans step up to participate in COVID-19 vaccine research

      Marshalltown Times-Republican· 3 days ago

      Moines, Dubuque and Ottumwa, these Iowans were driven by an important purpose: they were participating in the Pfizer-BioNTech clinical trial that would lead to the first emergency authorization ...